trial

Intervention to Improve Coping With Negative Emotions in Patients With Psychosis (Feel-Good-Study)

NCTId NCT04592042
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Completed
Enrollment 36 (actual)
Sponsored by Philipps University Marburg
Primary completion 2021-11-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2021-01-08
Primary completion
2021-11-01
Eligibility
ALL · 17 Years · 65 Years

Interventions & indications

Drugs
Feel-Good- Group

Sponsors

Philipps University MarburgLead Sponsor
Prof. Dr. Andreas Bechdolf (Chair of hospital), Vivantes Hospital Am Urban BerlinCollaborator
Prof. Dr. Nikola Stenzel (Collaboration partner), Berlin Psychological University, BerlinCollaborator
Dr. Karolina Leopold (Senior physician), Vivantes Hospital Am Urban BerlinCollaborator

Investigators

3
Nikola M Stenzel, Ph. D.Study Chair
Andreas Bechdolf, Prof. Dr.Study Director
Karolina Leopold, MDStudy Chair

Sites

1 total
Marburg, Germany

Facts & assertions

4 sourced
Enrollment
36
Phase
EARLY_PHASE1
Primary Completion Date
2021-11-01
Status
COMPLETED
relationships
The graph out of here
drug
Feel-Good- Group
drug
lead_sponsor
Philipps University Marburg
company
collaborator
Prof. Dr. Andreas Bechdolf (Chair of hospital), Vivantes Hospital Am Urban Berlin
company
Prof. Dr. Nikola Stenzel (Collaboration partner), Berlin Psychological University, Berlin
company
indication
Early Psychosis
indication
Delusions
indication
Emotional Regulation
indication
investigator
Nikola M Stenzel, Ph. D.
person
Andreas Bechdolf, Prof. Dr.
person
Karolina Leopold, MD
person